KDM6A-deficient bladder cancer cell lines show a loss of interaction with FOXA1, normally involved in urothelial differentiation, and a redistribution of transcription factor ATF3, further repressing FOXA1-target genes and activating cell cycle progression [112]. This evidence concerns the gene FOXA1 and urinary bladder cancer.